← Back

Greece EOF · Greece · 9 Sep 2026 · Guidance

Article 141(1) procedure: Quarter-based selective dry cow therapy

AI-generated summary

Marketing authorization holders must ensure that summaries of product characteristics, package leaflets, and labeling for veterinary medicines remain current with scientific knowledge, as required by EU Regulation 2019/6. Holders should consult the HMA website for Committee for Medicinal Products for Veterinary Use advice.

From Greece EOF

The MAHs are reminded of their duty to, according to Article 58(4) of Regulation (EU) 2019/6, ensure that the summary of product characteristics, package leaflet and labelling is kept up to date with current scientific knowledge.

Please refer to the website //www.hma.eu/veterinary-medicines/cmdv/advice-from-cmdv.html

Excerpt from the official page. The original is authoritative.